Literature DB >> 6687051

Occurrence of both urokinase and tissue plasminogen activator in the human endometrium.

B Casslén, B Astedt.   

Abstract

The presence of two different plasminogen activators, urokinase and tissue activator, in the endometrium was demonstrated immunologically. Tissue activator was prevalent and urokinase was present in only minor amounts in endometrial tissue extractions. In tissue culture, on the contrary, endometrial explants released more urokinase than tissue activator into the medium and the fibrinolytic activity of the medium was mainly due to urokinase. This may reflect different modes of intracellular storage of the two activators, or the presence of a pre-urokinase which is immunologically different from urokinase and which is activated upon release. The amount of urokinase and fibrinolytic activity released into the culture medium was higher when endometrium samples had been obtained in the midcycle phase than in the proliferative and luteal phases. This pattern mimics the in vivo release of plasminogen activator from the endometrium into the uterine fluid. Endometrium obtained from IUD-users had a higher content of urokinase than that obtained from non-users.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687051     DOI: 10.1016/0010-7824(83)90106-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

1.  Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3.

Authors:  Donna C Sinclair; Alex Mastroyannis; Hugh S Taylor
Journal:  J Clin Endocrinol Metab       Date:  2010-11-17       Impact factor: 5.958

2.  SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase.

Authors:  Robert Kuo-Kuang Lee; Chi-Chen Fan; Yuh-Ming Hwu; Chung-Hao Lu; Ming-Huei Lin; Ying-Jie Chen; Sheng-Hsiang Li
Journal:  Reprod Biol Endocrinol       Date:  2011-03-23       Impact factor: 5.211

3.  Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases.

Authors:  E Marbaix; I Kokorine; P Moulin; J Donnez; Y Eeckhout; P J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

4.  Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation.

Authors:  Schu-Rern Chern; Sheng-Hsiang Li; Chung-Hao Lu; Edmund I Tsuen Chen
Journal:  Reprod Biol Endocrinol       Date:  2010-10-27       Impact factor: 5.211

5.  A complex of novel protease inhibitor, ovostatin homolog, with its cognate proteases in immature mice uterine luminal fluid.

Authors:  Hsien-Lu Huang; Szu-Chin Li; Jin-Fong Wu
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.